The present study showed that berberine reduced the plasma levels of LDL and ApoB, inhibiting hepatic fat accumulation, and promoted the expression of liver LDLR mRNA significantly in hamsters with diabetes and hyperglycemia, confirming that berberine exerted the lipid-lowing effect by enhancing the expression of LDLR mRNA. The gene discussed is LDLR; the disease is diabetes mellitus.